Christie + Co
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

17/11/2017
Government has finally signed off on the devolution of health in London following an eight-month delay.
17/11/2017
Sir Mike Richards, the former national cancer director and chief inspector of hospitals for the Care Quality Commission will join PwC as a senior advisor, the consultancy firm has announced.
17/11/2017
The government’s green paper on social care funding will now not be published until summer 2018, cabinet office minister Damian Green has announced in a written statement.
16/11/2017
Earnings per share will be 130% lower for South African private hospital group Netcare in its financial year results to September, due to be published on Monday.
16/11/2017
Healthcare property developer Assura has announced plans to raise up to £300 million through a placing of 526,315,789 new ordinary shares.


Civica

Christie + Co

HealthInvestor Events


company profile: Baycroft

One Housing Group sets out its ambitions in the luxury care home market to Ploy Radford
Read more



private finance initiative

Labour has claimed it will bring PFI deals back in-house. KPMG partner Matthew Custance explores how beneficial PFI has actually been,, and for whom
Read more



HealthInvestor blog
Bhavna Keane-Rao, founder of BKR Care Consultancy, considers the difficulties with regulating healthcare apps

Click here to view the Editor's blog


Chairman and partner of Blake Morgan, Bruce Potter has helped evolve the models for the contracting of clinical services within the NHS
Candesic’s Dr Joe Taylor and Dr Michelle Tempest report on the outlook for health and social care policy from the Conservative and Labour party conferences
The growing shortfall in the number of elderly care beds spells disaster for our ageing demographics. Clare Connell and Henry Hunt of Connell Consulting investigate
One Housing Group sets out its ambitions in the luxury care home market to Ploy Radford
Labour has claimed it will bring PFI deals back in-house. KPMG partner Matthew Custance explores how beneficial PFI has actually been, and for whom

Click here to search all feature articles